126 related articles for article (PubMed ID: 36929436)
1. Good or bad cops: immune cells in aGVHD.
Stary G
Blood; 2023 Mar; 141(11):1238-1240. PubMed ID: 36929436
[No Abstract] [Full Text] [Related]
2. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
Front Immunol; 2018; 9():2724. PubMed ID: 30534126
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation.
de Koning C; Prockop S; van Roessel I; Kernan N; Klein E; Langenhorst J; Szanto C; Belderbos M; Bierings M; Boulad F; Bresters D; Cancio M; Curran K; Kollen W; O'Reilly R; Scaradavou A; Spitzer B; Versluijs B; Huitema A; Lindemans C; Nierkens S; Boelens JJ
Blood; 2021 Feb; 137(6):848-855. PubMed ID: 33150379
[TBL] [Abstract][Full Text] [Related]
4. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
Front Immunol; 2018; 9():669. PubMed ID: 29740427
[TBL] [Abstract][Full Text] [Related]
5. How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-
Vandenhove B; Canti L; Schoemans H; Beguin Y; Baron F; Graux C; Kerre T; Servais S
Front Immunol; 2020; 11():583564. PubMed ID: 33193397
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of acute graft-vs.-host disease.
Pietryga D
Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):28-48. PubMed ID: 8383475
[TBL] [Abstract][Full Text] [Related]
7. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
Front Immunol; 2021; 12():647894. PubMed ID: 34262560
[TBL] [Abstract][Full Text] [Related]
8. Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells.
Engelhardt BG; Crowe JE
Curr Top Microbiol Immunol; 2010; 341():121-46. PubMed ID: 20563712
[TBL] [Abstract][Full Text] [Related]
9. Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.
Schultz KR; Kariminia A; Ng B; Abdossamadi S; Lauener M; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savasan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; Azadpour S; Ostroumov E; Subrt P; Halevy A; Mostafavi S; Cuvelier GDE
Blood; 2020 Apr; 135(15):1287-1298. PubMed ID: 32047896
[TBL] [Abstract][Full Text] [Related]
10. Type 2 innate lymphoid cells from Id1 transgenic mice alleviate skin manifestations of graft-versus-host disease.
Srinivasan A; Bajana S; Pankow A; Yuen C; Shah RK; Sun XH
BMC Immunol; 2021 Jul; 22(1):46. PubMed ID: 34256699
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytoid dendritic cells and Th17 immune response contribution in gastrointestinal acute graft-versus-host disease.
Bossard C; Malard F; Arbez J; Chevallier P; Guillaume T; Delaunay J; Mosnier JF; Tiberghien P; Saas P; Mohty M; Gaugler B
Leukemia; 2012 Jul; 26(7):1471-4. PubMed ID: 22333879
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Tc17 cells at early stages after allogeneic hematopoietic stem cell transplantation with acute graft-versus-host disease.
Wang L; Zhao P; Song L; Yan F; Shi C; Li Y; Han M; Lan K
Int Immunopharmacol; 2016 Dec; 41():122-126. PubMed ID: 27846420
[TBL] [Abstract][Full Text] [Related]
13. Establishment of an acute graft-versus-host disease model following liver transplantation in donor-dominant one-way major histocompatibility complex matching rats.
Xue F; Chen W; Wang XG; Liang L; Bai XL; Wang LY; Wang HP; Liang TB
Transplant Proc; 2009 Jun; 41(5):1914-20. PubMed ID: 19545756
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Xu J; Wei J; Zhu X; Zhang X; Guan J; Wang J; Yin J; Xiao Y; Zhang Y
Biol Blood Marrow Transplant; 2013 Feb; 19(2):196-201. PubMed ID: 23089565
[TBL] [Abstract][Full Text] [Related]
15. The expression of Th17-associated cytokines in human acute graft-versus-host disease.
Liu Y; Cai Y; Dai L; Chen G; Ma X; Wang Y; Xu T; Jin S; Wu X; Qiu H; Tang X; Li C; Sun A; Wu D; Liu H
Biol Blood Marrow Transplant; 2013 Oct; 19(10):1421-9. PubMed ID: 23792271
[TBL] [Abstract][Full Text] [Related]
16. Acute graft-versus-host disease-challenge for a broader application of allogeneic hematopoietic cell transplantation.
Zeiser R; Beilhack A; Negrin RS
Curr Stem Cell Res Ther; 2006 May; 1(2):203-12. PubMed ID: 18220867
[TBL] [Abstract][Full Text] [Related]
17. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
[TBL] [Abstract][Full Text] [Related]
18. Endothelial microparticles carrying hedgehog-interacting protein induce continuous endothelial damage in the pathogenesis of acute graft-versus-host disease.
Nie DM; Wu QL; Zheng P; Chen P; Zhang R; Li BB; Fang J; Xia LH; Hong M
Am J Physiol Cell Physiol; 2016 May; 310(10):C821-35. PubMed ID: 27009877
[TBL] [Abstract][Full Text] [Related]
19. Increased Galectin-9 expression, a prognostic biomarker of aGVHD, regulates the immune response through the Galectin-9 induced MDSC pathway after allogeneic hematopoietic stem cell transplantation.
Yin J; Li L; Wang C; Zhang Y
Int Immunopharmacol; 2020 Nov; 88():106929. PubMed ID: 32889240
[TBL] [Abstract][Full Text] [Related]
20. Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.
Yucebay F; Matthews C; Puto M; Li J; William B; Jaglowski SM; Penza SL; Vasu S; Benson DM; Andritsos LA; Devine SM; Efebera YA; Roddy JVF
Leuk Lymphoma; 2019 Sep; 60(9):2223-2229. PubMed ID: 30764681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
